The therapy delivers the full-length ABCA4 protein and has the potential to benefit all patients with ABCA4 mutations
Minister releases five breakthrough veterinary technologies to strengthen diagnostics and combat antimicrobial resistance
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
This collaboration aims to bridge India’s talent and translational gap in this rapidly growing field by equipping professionals with practical expertise in the manufacturing of advanced therapies.
Capricor’s BLA for Deramiocel received Priority Review in March 2025
IGI partners with AbbVie and grants exclusive rights to globally develop, manufacture, and commercialize ISB 2001 across North America, Europe, Japan, and Greater China
This year, 40 women students are participating, selected through a rigorous process evaluating academic merit, research interest, and socio-economic background
Addresses brain metastases harboring BRCA1/2 and/or HRR alterations—an area of high unmet need
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
Capstan's lead asset, CPTX2309, is a targeted lipid nanoparticle (tLNP) that delivers an mRNA encoding an anti-CD19 chimeric antigen receptor (CAR) to CD8-expressing cytotoxic T cells in vivo
Subscribe To Our Newsletter & Stay Updated
